Post My Press Release

Free Press Release Distribution

Author: rajkumar@coherentmarketinsights.com (Page 1 of 71)

Uterine Cancer Drugs Market – Trends, Outlook, and Opportunity Analysis, 2018-2026

Uterine cancer is one of the most common gynecologic malignancy among female cancer patients. This uterine cancer is of two types: endometrial cancer and uterine sarcoma. Endometrial cancer is caused due to uncontrolled growth of inner linings of uterus. Endometrial cancer is often curable, however, uterine sarcoma is rare cancer, which develops in the muscle and supporting tissues of the uterus (womb). According to National Cancer Institute, Megestrol Acetate is only drug approved by U.S. Food and Drug Administration (FDA) for the treatment of endometrial cancer till March 2016. Diagnosis of both types of uterine cancer is done through endometrial biopsy, colposcopy or Pap smear screening test.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1745

Uterine Cancer Drugs Market Drivers

Increasing funding for cancer research, rising insurance coverage, and increasing number of new targeted cancer drugs are supporting the revenue growth of uterine cancer drugs market size. For instance, National Cancer Institute, in 2015, invested around US$ 4,480 million on cancer research, which include uterine cancer, cervical cancer, lung cancer, colorectal cancer, liver cancer, breast cancer, leukemia, and ovarian cancer. Furthermore, according to the American Cancer Society, U.S. has spent around US$ 87.8 billion in 2014, on cancer research, in which the major cost accounting for around 44%, was paid by private insurance companies.

Chemotherapy is the most recommended therapy suggested for treatment of uterine sarcomas. However, chemotherapy may not work in certain types of uterine sarcoma. Chemotherapy for uterine sarcoma is often conducted in the earlier stages of cancer. Various chemotherapy drugs used in the treatment of uterine sarcoma include Paclitaxel (Taxol), Docetaxel (Taxotere), Dacarbazine (DTIC), Liposomal doxorubicin (Doxil), Epirubicin (Ellence), and among others.

Uterine Cancer Drugs Market – Regional Analysis

Geographically, uterine cancer drugs market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. According to World Health Organization (WHO) 2018 data findings, cervical cancer is the fourth most frequent type of cancer in women, which accounted for an estimated 530,000 new cases in 2012, representing 7.9% of all female cancers. Furthermore, according to WHO: 2018, around 90% the 270,000 deaths from cervical cancer in 2015 are occurred in low- and middle-income countries. Furthermore, the prevalence of endometrial cancer is higher in developed economics such as the in North America and the Europe, owing to changing lifestyles of women in these countries. The prevalence of uterine cancer is more common in women aged 50 years and above.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1745

Uterine Cancer Drugs Market Competitive Landscape

Some of the key players operating in the uterine cancer drugs market include Merck & Company, Inc., Actiza Pharmaceutical Private Limited, United Biotech Pvt Ltd, Elder Pharmaceuticals Ltd, Par Pharmaceutical Companies, Inc. and among others.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Implantable Bioartificial Kidney Market – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

An implantable bioartificial kidney is similar to existing extracorporeal renal assist device (RAD), which is a bioartificial kidney that combines a membrane hemofilter and a bioreactor to function as a healthy kidney. However, to work as a natural kidney, the bioartificial kidney should have high efficiency ultrafiltration membranes, should be able to regulate blood flow, and stabilize necessary cells. Implantable bioartificial kidney is capable of replicating the work of real kidney and can eliminate the need for dialysis. Implantable bioartificial kidney avoids constant physician oversight and need to take immunosuppressant drugs and medication.

For In depth Information Get Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2339

Implantable Bioartificial Kidney Market: Drivers

Increasing number of chronic kidney disease patients, rising number of kidney failure incidences, and long waiting list for kidney transplants is expected to boost the global implantable bioartificial kidney market growth over the forecast period. For instance, according to Kidney Health Australia, 2010, the cost of treating all current and new cases of End Stage Kidney Disease (ESKD) will reach up to US$ 12 billion by 2020. Moreover, according to the Centers for Disease Control & Prevention (CDC), around 15% of the adults in the U.S. were estimated to have chronic kidney disease in 2017. CDC states that around 96% of the people with kidney damage or hampered kidney function are not aware of having chronic kidney disease. These factors are expected to drive the global implantable bioartificial kidney market growth over the forecast period.

Individual government organizations and manufacturers are working towards increasing the awareness of kidney diseases. For instance, American Kidney Fund (AKF) launched a comprehensive new kidney disease education portal in May 2018. The education portal called as ‘CKD Central’ will provide information and resources on chronic kidney disease (CKD). Moreover, The Kidney Project is a national research project, which aims to create a small, surgically implanted, and free-standing bioartificial kidney to treat end stage renal disease (ESRD). This kidney is expected to provide ESRD patients with a new option beyond the short-term solution of renal dialysis and the costly kidney transplant for which donor organs are limited.

Stringent regulatory policies for the approval and manufacturing, reimbursement, and risks and complications associated with dialysis treatment are expected to restrain the global implantable bioartificial kidney market growth over the forecast period.

Implantable Bioartificial Kidney Market: Regional Analysis

North America implantable bioartificial kidney market is expected to hold dominant position in the global market over the forecast period. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), over 661,000 people in the U.S. had kidney failure and of these, 468,000 individuals were on dialysis, in 2017. The kidney project, headed by researchers from the University of California San Francisco (UCSF), the University of Vanderbilt, and the National Institute of Biomedical Imaging and Bioengineering (NIBIB), is expected to receive approval for the artificial kidney trials by late 2018 or early 2019. These factors are expected to support the North America implantable bioartificial kidney market growth over the forecast period. According to report of Brazilian Transplant Registry, 2016, Brazil accounts for the second largest number of kidney transplant programs in the world.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2339

Implantable Bioartificial Kidney Market: Taxonomy

The global implantable bioartificial kidney market is segmented on the basis of end user, and region.

By End User:

  • Hospitals
  • Organ Transplant Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Medical Sensors Market World Top Most Players Forecasts Significantly by 2026

Medical sensors that measure the physical functions of the body and convert it into an electrical or optical signal. These devices play a major role in the monitoring of chronic diseases such as cancer, cardiovascular and respiratory diseases to measure the physical function and convert it into the electrical signal. The market is majorly directed by the increased demand for medical sensors in diagnostic and therapeutic segments. The medical sensor monitor adds value to the healthcare professional to alert critical deviations, which are recorded in vital signs. This ultimately improves the quality of care given to the patient by avoiding undesirable complications. Moreover, the demand for medical sensors is raised because of its wide range of applications such as monitoring of temperature, pressure, vibration, inclusive of various diagnostic parameters and analysis. As increase in chronic disorders and geriatric population globally has continuously raised the demand for these equipment. Furthermore, chronically ill patients and geriatric population are the target area for sensor-based devices, for instance as per National Institute of Aging, there are around 617 million people above the age of 65 years in 2016 and it will cross 1.6 billion by 2050.

Request For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/578

Improved Technology And Accuracy Fuels The Growth Of Medical Sensors Market

Medical sensors have become a universal segment of the technologically advanced and digital medical devices. There is a significant increase in the development of implantable and wearable medical devices, which facilitate the awareness about medical devices this leads to the increased use of sensors. It is expected that rise in geriatric population, increase in chronic diseases such as chronic obstructive pulmonary disease (COPD), cardiovascular disease, kidney disease and respiratory disease and rise in intensive care for critical patients are the responsible factors supports the growth of medical sensors market. As per Centers for Disease Control and Prevention, there are around 15.7 million people in the U.S. diagnosed with COPD in 2014. Furthermore, there is a wide range of benefits of the use of medical sensors in medical devices, which increased the accuracy in disease management through notifications alerts, and real time patient data communication. Which expected to support the growth of medical sensors market.

Developed Regions Are Major Growth Engines For Medical Sensors Market

Medical sensors market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America is the leading region due to the annual increase in minimally invasive surgeries performed and availability of healthcare reimbursement policy. However, market across Asia Pacific is expected to expand at a higher rate due to, increase in diabetic population, respiratory diseases cases, cardiovascular disease and raised investment in healthcare sector in emerging countries such as India and China expected to support the growth of medical sensors market.

Key Players of the Medical Sensors Market

There are various players present across the globe and running into the competition. The rise in awareness about devices and increase in per capita income of individuals expected to create more opportunities for industry players in global medical sensors market. Some key players are Analog Devices Inc., Broadcom Limited, Danaher, LORD Corporation, Honeywell International Inc., OmniVision Technologies Inc., and GE Measurement & Control.

Medical Sensors Market Taxonomy:

By Application –

  • Surgical
  • Diagnostic
  • Therapeutic
  • Monitoring

By Product Type –

  • Pressure
  • Temperature
  • Image
  • Accelerometers
  • Biosensors
  • Flow
  • Superconducting Quantum

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/medical-sensors-market-578

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Stem Cell Cartilage Regeneration Market – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Stem cells therapy are emerging as an important therapeutic option in the field of cartilage regeneration. Rapid development of stem cell-based therapy for cartilage regeneration in the recent past has been witnessed across the world. Stem cells are mainly classified in three kinds of cells: hematopoietic stem cell, mesenchymal stem cells, and pluripotent stem cells.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2448

The global stem cell cartilage regeneration market size was valued at US$ 254.4 million in 2017, and is expected to witness a CAGR of 8.9% over the forecast period (2018 – 2026).

Increasing Adoption of Minimally Invasive Surgery Procedures is expected to Drive Growth of Stem Cell Cartilage Regeneration Market

Stem cell therapy for knees, minimally invasive procedure, has the potential to decrease inflammation, halt progression of arthritic damage, repair joint cartilage, and delay or avoid knee replacement surgery. Injection of progenitor cells, especially mesenchymal stem cells (MSCs), has been found to be an effective and better solution for repairing degenerative cartilage compared to implantation of differentiated cells such as articular cartilage.

In addition to this, other potential benefits such as lower risk and shorter duration of minimally invasive surgery procedures are expected to fuel demand for stem cell therapy for cartilage regeneration during the forecast period. For instance, according to NCBI 2016 report, a minimally invasive procedure to harvest stem cells from both fat and bone marrow and inject the concentrated cells under image guidance can be performed in 2-3 hours.

Market Dynamics

Growing osteoarthritis incidence among the global population is supporting the adoption of stem cell cartilage regeneration therapy. For instance, according to November 2017, Arthritis Foundation data findings, with the increase in global geriatric population, degenerative disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050.

Furthermore, various government agencies are focusing on policies to enhance adoption of stem cell therapies, which is expected to drive growth of stem cell cartilage regeneration market in the near future. For instance, in December 2016, the 21st Century Cures Act (Cures Act) was signed into law by the U.S. FDA, thereby allowing legislation for an expedited approval path for cellular medicines designated as regenerative medicine advanced therapies (RMATs) to patients who are in need of it.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2448

Stem Cell Cartilage Regeneration Market – Competitive Landscape

Key players operating in the global stem cell cartilage regeneration market include Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Melanoma Treatment Market Perspective with Study of Leading Players 2018 – 2026

Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in the treatment and increase survival rates. According to the American Academy of Dermatology 2015 report, the prevalence of melanoma is increasing and spreads to other body parts as well. As it spreads to other body parts, its treatment becomes much more complex. The rare genetic conditions such as xeroderma pigmentosum also increase the risk of melanoma and it is diagnosed with the biopsy of any skin lesion.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/719

Development of new drugs fuels the melanoma treatment market

Several drugs in the market have already received FDA approval for melanoma treatment and some are under development. Drugs such as seviprotimut-L by Polynoma’s, talimogene laherparepvec (T-VEC) by Amgen Inc., and zelboraf, by Roche and Genetech together for the treatment of cutaneous melanoma are under development. Selumetinib is under development by AstraZeneca for the treatment of ocular melanoma. In 2011, Yervoy, a monoclonal antibody drug was developed by Bristol-Myers Squibb for the treatment of melanoma and it is the first drug to receive FDA approval. Immunotherapy drugs include opdivo and keytruda, which got FDA approval and created new opportunities in melanoma treatment market. When chemotherapy fails to deliver results, targeted therapy is used, which include BRAF inhibitors. Targeted therapy has limited side effects in comparison with chemotherapy.

Developed regions support the growth of melanoma treatment market

Melanoma treatment market, based on geography, is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the melanoma treatment market due to the high prevalence of melanoma in the region along with well-developed healthcare facilities and increased research and development on melanoma drugs. Moreover, reimbursement policy and increase in per capita income are expected to fuel the melanoma treatment market. Europe is the second largest market and is expected to grow significantly in near future due to increase in melanoma cases and development of novel therapies. Asia Pacific is expected to exhibit moderate growth due to fewer cases of skin cancer, lack of awareness, and high cost of melanoma drugs.

Key Players in the Global Melanoma Treatment Market

Some of the key players identified across the value chain of global melanoma treatment market are Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genetech Inc., Novartis AG, Polynoma LLC, AstraZeneca, Amgen Inc., Sanofi, Merck & Co. Inc., and Takeda Pharmaceutical Company.

Melanoma Treatment Market Taxonomy:

The global melanoma treatment market is segmented as follows;

By Melanoma Type;

  • Cutaneous Melanoma
  • Mucosal Melanoma
  • Ocular Melanoma

By Therapy;

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Surgical Treatment
  • Pharmacological Treatment

Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/melanoma-treatment-market-719

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Parenteral Packaging Market To Receive Overwhelming Hike In Revenues By 2025

Parenteral packaging is the process of packaging drugs or other fluids to keep its potency and therapeutic effectiveness intact throughout the time till the drug is administered. Parental packaging is required to protect drugs from contamination and from the aseptic administration to the patient. On the basis of materials parenteral packaging market is segmented into plastic & polymer and glass segments. The plastic and polymer are more durably then glasses used for parenteral packaging. The pharmaceuticals sector has witnessed significant technological advancements in the recent past. As a result, recent advancement in routes of drug administration is shaping the market demand for parenteral packaging.

Request for Sample Copy of This Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/565

Continuous rise in chronic disease cases is expected to support the demand of parenteral drugs which in turn support the growth of parenteral packaging market in the near future. Asthma is one of the major chronic disease of air passages of the lungs. According to the World Health Organization (WHO) around 235 million people are suffering currently from asthma, it was estimated around 383,000 deaths occurred due to asthma in 2015 and the strong risk factor for asthma are inhaled substances and particles that causes allergic reaction which are exposed in environment. The fundamental causes of asthma can be tobacco smoke, chemical irritants at the workplace and air pollution.

The global parenteral packaging market was valued at US$ 7,845.7 million in 2016 and is expected to witness a robust CAGR of 11.1% during the forecast period (2017 – 2025)

Market Dynamics:

Increase in the prevalence of Alzheimer’s disease (AD) and aging population around the globe is expected to favor the growth in parenteral packaging market. According to the World Health Organization (WHO), the AD cases worldwide was estimated to be around 47 million and it will increase around 75 million by 2030 and the number of cases is expected to triple by 2050, due to the high prevalence rate and lack of healthcare services in rural areas. Also, increase in aging population and rise in demand for medication in the treatment of lifestyle diseases such as diabetes, are the other factors leading to the increase in use of parenteral drugs in developed and emerging economies. As per the SeniorCare the U.S. aging population was estimated to be around 50,683,620 in 2016 and is expected to be around 71,453,471 by the year 2030. And according to the National Institute on Aging (NIA) population worldwide is around 8.5% and it will rise around 17% by the year 2050.

Increase in incidence of cancer around the globe expected to support the growth of parenteral packaging market over the forecast period

North America holds the major market share, followed by Europe in the global parenteral packaging market. This is mainly due to rise in cancer case is projected to favor the growth of parenteral packaging market. According to the American Cancer Society (ACS) in the U.S. it was estimated that in 2016 around 1,685,210 cases of cancer was diagnosed and around 595,690 cancer deaths occurred this is due to the high risk factors such as smoking of cigarettes, consumption of alcohol and obesity rate this will led to the high proportion of chronic diseases in the U.S.

Market Top Key Players:

Key players in the parenteral packaging market include Gerresheimer AG, Schott AG, Becton, Unilife Corporation, Inc, Dickinson and Company, Ypsomed Holding AG, West Pharmaceutical Services, Inc., SiO2 Medical Products, Terumo Corporation, Ompi, Stevanato Group and Nipro Corporation, Berry Plastics Corporation, Becton Dickinson and Company, MeadWestvaco Corporation, Owens-Illinois, RPC Group, Schott Pharmaceuticals Services Inc., and Graphic Packaging Group.

Detailed Segmentation:

Parenteral Packaging Market, By Technique:

  • Bags and bottles
  • Ampoules
  • Vials
  • Prefilled syringes & cartridges
  • Ready-to-mix-systems

Parenteral Packaging Market, By Material:

  • Glass
  • Plastic and polymer
  • PVC
  • polyolefin

Browse Full Report Here: https://www.coherentmarketinsights.com/market-insight/parenteral-packaging-market-565

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Teleradiology Market to Undertake Strapping Growth During 2018 to 2026

Teleradiology is a method used to transmit medical radiological images such as x-rays, CTs, and MRIs, from one location to another location. The purpose of this transmission of medical images is to enable easy viewing and interpretation for diagnostic or consultation by a radiologist. The process of teleradiology involves an image sending station, a receiving image station, and a transmission network that has high quality screen, which has been cleared for clinical purposes. Teleradiology is a means for collaboration of medical professionals, despite their location. Increasing demand for second opinion for medical treatments is expected to boost growth of the market for teleradiology.

Teleradiology is widely used in application such as telediagnosis, telemonitoring, picture archiving and communication system (PACS), and teleconsultation. This increases the efficiency of the radiologist carrying out the surgery. Ultrasound is one of the most promising imaging technology in teleradiology, which is widely being used for diagnosing medical aliments in women. Ultrasound helps in tracking and visualization of the development stages of fetus during pregnancy. This in turn increases growth of the teleradiology market.

Ask for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/549

Rising prevalence of chronic diseases to boost market growth

Rising prevalence of chronic disorders such as breast cancer, cellulitis, and osteomyelitis and the rising number of emergence cases in rural areas, which experiences the lack of skilled professional, are increasing demand for teleradiology services. Furthermore, rising expenditure on healthcare, improving healthcare infrastructure, and widening network of high-speed broadband services are expected to boost growth of the global market.

North America and Europe are expected to account for high market share, followed by Asia Pacific due to the rampant advancements in technology and high disposable income among the populace in the region. Increasing number of well-equipped healthcare centers and novel approaches to medicine are expected to fuel growth of the teleradiology market. Increasing incidence of chronic diseases such as cancer is creating a highly conducive environment for growth of the teleradiology market. For instance, according to the World Health Organization (WHO), in 2012, around 14 million cases of cancer were reported worldwide, leading to around 8.8 million deaths in 2015.

Key Players of Teleradiology Market:

Key players in the teleradiology market include Virtual Radiologic (vRAD), NightHawk Radiology, Inc., Sectra Imtec AB, StatRad, LLC, Agfa-Gevaert N.V., ONARD, Global Diagnostics, Everlight Radiology, 4ways Healthcare Limited, RamSoft, Inc., Sectra AB, Health Watch Tele Diagnostics Pvt. Ltd., Alta Vista Teleradiology, Argus Radiology, ONRAD, Inc., FujiFilm Medical Systems.

Teleradiology Market Taxonomy –

By Product:

  • Computed Tomography (CT)
  • X-ray
  • Ultrasound
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging

By Application:

  • Tele-diagnosis
  • Tele-consultation
  • Tele-monitoring
  • Picture Archiving and Communication System (PACS)
  • Radiology Information System (RIS)

Browse Complete Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/teleradiology-market-549

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Ostomy Care Market Growth And Latest Trends 2018-2026

Ostomy refers to a surgical procedure that allows the passage of bodily wastes through a surgically created stoma or aperture on the abdomen into a prosthetic such as a pouch or bag placed outside the body. Ostomy is performed on patients suffering from various medical conditions, including cancer, birth defects, diverticulitis, incontinence, and inflammatory bowel disease. This procedure is also performed on patients suffering from severe abdominal and pelvic trauma caused due to accidents or severe injuries. Ostomy is also known as continent diversion surgery and can be performed on patients of all age groups. The procedure does not affect life expectancy of an individual.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1687

Ostomy leads to elimination of waste material from the body through stoma, which is part of the intestine that lacks presence of contraction muscles, thus resulting in loss of control of the individual on excretion of gas or solid waste from the body. The waste is automatically collected in a plastic bag or pouch that holds the waste and helps block the smell at the same time. Ostomy leads to rerouting of bodily waste from its usual path that can result due to malfunctioning parts of the digestive or urinary system. Depending on the severity of the patient, the ostomy can be temporary or permanent. The most common types of ostomies involve colostomy, ileostomy, urostomy, J-pouch, and continent urostomy among others.

Market Dynamics

The rising number of ostomy procedures being performed is the primary factor responsible for driving growth of the global ostomy care market. For instance, according to National Center for Biotechnology Information, around 100,000 people underwent operations resulting in colostomy or ileostomy in the U.S., in 2014. Increasing prevalence of inflammatory bowel disease is also expected to increase the demand for ostomy care. For instance, according to a research survey published in ‘The Lancet’ in October 2017, western countries suffer with a high prevalence of inflammatory bowel disease that has surpassed 0.3% of the total population. Moreover, according to the Worldwide Incidence and Prevalence of Inflammatory Bowel Disease (IBD) in the 21st Century: A Systematic Review of Population-Based Studies 2017, the incidence of IBD and Crohn’s disease is increasing in Latin America, Africa, and Asia Pacific. Various other factors responsible for the growth of market include rising incidence of bladder cancer, birth defects, and technological advancements. For instance, around 10,171 cases of bladder cancer were reported in the U.K. in 2015, out of which 50% cases survived through proper medication and care. However, low awareness in underdeveloped and developing economies regarding the availability of treatments and increasing pricing pressure on the manufacturer is expected to confine the market growth.

Regional Insights

On the basis of region, the global ostomy care market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global ostomy care market and is expected to retain its dominance over the forecast period, owing to large population suffering from Crohn’s disease, inflammatory bowel diseases, and other diseases in the region. According to the Centers of Disease Control and Prevention, around 1.3% of the adults in the U.S., accounting up to 3 million patients were reported to be suffering from inflammatory bowel disease in 2015 that increased the overall hospitalization rate in the country.

Furthermore, Asia Pacific is expected to witness a significant growth in the market, which is attributed to increasing efforts undertaken by government and non-government organization to support research, generate awareness, and increase the availability of treatment options to patients in their native countries. For instance, the Japan Ostomy Education is a non-profit organization approved by Ministry of Health, Labor and Welfare in Japan that conducts various activities concerned with stoma care for delivering a better life to patients suffering from related medical issues in Japan.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/ostomy-care-market-1687

Competitive Insights

Key players operating in the global ostomy care market include 3M Company, Coloplast Corporation, ConvaTec, Inc, Hollister, Inc., Smith & Nephew Plc, Alcare, Nu-Hope, Welland Medical, Cymed, and Flexicare Medical. Market players are focused on providing technologically advanced products, to sustain their position in the competitive market. For instance, in March 2015, Welland Medical introduced Aurum 2, a range of 2-piece ostomy pouches that is inclusive of flange with added medical grade Manuka honey.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Page 1 of 71

Powered by WordPress & Theme by Anders Norén